Agenda - Day 1 - January 10 | Biotech Showcase

All times are in PST

Day 1 - January 10 06:30 - 07:3060 mins

Networking

BiotechBikers Virtual Zwift and Peloton Ride and Networking

Day 1 - January 10 08:00 - 09:0060 mins

Biotech Showcase 1

Outsmarting Cancer: Next Generation Therapies

Kevin DeGeeter - Managing Director, Healthcare Research, Oppenheimer & Co. Inc.
William Ho - CEO, In8bio
Kanya Rajangam - CMO, Nkarta Therapeutics
Spiro Rombotis - President and CEO, Cyclacel Pharmaceuticals
Weimin Tang - CBO, I-Mab Biopharma
Lihua Zheng - CBO and Co-Founder, AnHeart Therapeutics

Day 1 - January 10 08:00 - 09:0060 mins

Biotech Showcase 2

Psychedelics: Once Stigmatized, Are Now the Newest Therapeutics on the Block for Mental Health

Walter Greenleaf - Distinguished Visiting Scholar, Stanford University’s MediaX Program
Bob Dougherty - VP, Digital Health Research, COMPASS Pathways
Doug Drysdale - CEO, Cybin
Adam Gazzaley - David Dolby Distinguished Professor of Neurology, Physiology & Psychiatry, UC San Francisco
Berra Yazar-Klosinski - CSO, Multidisciplinary Association for Psychedelic Studies (MAPS)

On Demand

Company Presentations

Company presentations will be held On-Demand for viewing in the partneringONE system.

Day 1 - January 10 08:00 - 08:2020 mins

Additional Programming: Cell and Gene Therapies State of the Industry Briefing

ARM Cell and Gene State of the Industry Briefing: Introduction & Industry Update

Janet Lambert - CEO, Alliance for Regenerative Medicine
Emile Nuwaysir - CEO, Ensoma; Chairman, Alliance for Regenerative Medicine (ARM); Chairman, CEO, BlueRock Therapeutics

Day 1 - January 10 08:20 - 09:0545 mins

Additional Programming: Cell and Gene Therapies State of the Industry Briefing

2022: A Banner Year for Rare Genetic Disease Therapies?

Bob Smith - SVP, Global Gene Therapy Business, Pfizer Inc.
Harold Bernstein - Chief Medical Officer and SVP, BioMarin
Jason Cole - CBO, bluebird bio
Bobby Gaspar - CEO, Orchard Therapeutics
Suma Krishnan - Founder and COO, Krystal Biotech

Day 1 - January 10 09:00 - 10:0060 mins

Biotech Showcase 1

The Decision to Launch on your Own: Critical Success Factors

Todd Matthews - Senior Director, Corporate Alliances, IQVIA
Christoph Broja - Principal, Gurnet Point Capital
Susan Kitlas - VP, Precommercial Segment Lead, IQVIA
Francesco Lavino - CEO, F2G

Day 1 - January 10 09:05 - 09:5045 mins

Additional Programming: Cell and Gene Therapies State of the Industry Briefing

Next Generation Therapies to Fight Cancer

Robert Ang - CEO, Vor Biopharma
Osvaldo Flores - CEO, Century Therapeutics
Steven Kelly - President and CEO, CARISMA Therapeutics
Alison Moore - Chief Technical Officer, Allogene Therapeutics

Day 1 - January 10 10:30 - 11:0030 mins

Biotech Showcase 1

Royalty Licenses: An Economic Asset Often Ignored

Tom Burns - Senior VP, Finance and CFO, XOMA
James R. Neal - CEO and Member, Board of Directors, XOMA
Juliane Snowden - Founder, The Oratorium Group

Day 1 - January 10 12:00 - 13:0060 mins

Biotech Showcase 1

Beyond the COVID-19 Crisis: What We Learned in Record Time and How it Will Advance the Future

Jeremy Abbate - Publisher, Scientific American
Mara Aspinall - Managing Director, Health Catalysts Group
Rick Bright - CEO, Pandemic Prevention Institute & Senior VP, Pandemic Prevention & Response, Health Initiative, The Rockefeller Foundation
Michael Brooks - Chief Development Officer and Global Head, Clinical Development Solutions, Syneos Health
Michelle McMurry-Heath - President and CEO, Biotechnology Innovation Organization (BIO)

Day 1 - January 10 14:45 - 15:4560 mins

Digital Medicine and Medtech Showcase

Investment Trends in Digital Medicine

Katya Hancock - Investment Network Director, StartUp Health
David J. Kim - Managing Director, DigiTx Partners
Dennis J. Purcell - Founder and Senior Advisor, Aisling Capital
Liz Rockett - Managing Director, Kaiser Permanente Ventures

Day 1 - January 10 16:00 - 17:0060 mins

Biotech Showcase 1

Investing for Commercial Success as an Emerging Company

Naveen Murthy - Senior Managing Director, Head of Product & Franchise Strategy, Commercial Advisory Group, Consulting, Syneos Health
Sachin Purwar - Director of Commercial Advisory Group, Consulting, Syneos Health
Michael Sarshad - Director of Commercial Advisory Group, Consulting, Syneos Health

Day 1 - January 10 16:30 - 17:3060 mins

Biotech Showcase 2

Pharma Perspective: A Post-Pandemic Time of Transformation

Bryan Katz - Senior VP and Global Head, Solution Development, Syneos Health
Phyllis Barkman Ferrell - Global Head, External Engagement, Alzheimer’s disease and Neurodegeneration, Eli Lilly & Company
Chihiro Hosoya - Head of Venture Management and Business Development, Astellas Rx+ Business Accelerator
Philippe Lopes-Fernandes - Executive VP and CBO, Ipsen
John McDonald - Corporate VP, Global R&D Business Development, Novo Nordisk

Day 1 - January 10 - PST/PDT (Pacific Daylight, GMT-7)

Day 1 - January 10 - PST/PDT (Pacific Daylight, GMT-7)